Singh, Rishi P.
Welch, Lauren
Longo, Nicole L.
Frese, Matt
Funding for this research was provided by:
Regeneron Pharmaceuticals, Inc
Article History
Received: 8 February 2023
Accepted: 10 June 2023
First Online: 22 June 2023
Declarations
:
: Data was collected as part of an observational retrospective review. All data used in the study was de-identified. Study participants provided informed consent to participate in the research. As per guidelines from the U.S. Department of Health and Human Services on Protection of Human Research Subjects—sections (d) (2) (i) and (ii) and (d) (4) (i) and (ii) of 46.104 Exempt Research—this study meets criteria for Exempt Research; thus, Institutional Review Board approval was not needed.
: Informed consent was obtained from all subjects and/or their legal guardian(s) for publication of identifying information/images in an online open-access publication.
: RPS has received personal fees from Genentech/Roche; Alcon/Novartis; Zeiss; Bausch + Lomb; Regeneron Pharmaceuticals, Inc; Gyroscope; and Asceplix. RPS has received grant funding from Apellis and Graybug. LW, NLL, and MF are employees of Med Learning Group.